리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2025년 07월
페이지 정보:영문 247 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 경카테터 심장판막 시장은 2030년까지 436억 달러에 달할 전망
2024년에 173억 달러로 추정되는 세계의 경카테터 심장판막 시장은 2030년에는 436억 달러에 달하며, 분석 기간인 2024-2030년의 CAGR은 16.6%로 성장할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 경카테터 대동맥판(TAV)은 CAGR 16.9%를 기록하며, 분석 기간 종료까지 314억 달러에 달할 것으로 예측됩니다. 경카테터 승모판(TMV) 부문의 성장률은 분석 기간에 CAGR 15.9%로 추정됩니다.
미국 시장은 44억 달러, 중국은 CAGR 21.2%로 성장 예측
미국의 경카테터 심장판막 시장은 2024년에 44억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 111억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 21.2%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 11.6%와 14.1%로 예측됩니다. 유럽에서는 독일이 CAGR 약 12.8%로 성장할 것으로 예측됩니다.
세계의 경카테터 심장판막 시장 - 주요 동향과 촉진요인 정리
경피적 카테터 심장 판막이 심장병학의 판도를 바꿀 수 있는 이유는 무엇인가?
경카테터 심장 판막 치환술은 대동맥판막 협착증과 같은 심각한 심장 판막 질환을 앓고 있는 환자들에게 기존의 개심술을 대체할 수 있는 최소 침습적 수술을 제공함으로써 심장학 분야의 획기적인 진보를 상징합니다. 큰 흉부 절개와 인공 심폐 장비가 필요한 기존의 외과적 판막 치환술과 달리, 경카테터 심장 판막 치환술은 일반적으로 살서제나 가슴의 작은 절개창을 통해 카테터를 통해 접이식 판막을 삽입합니다. 일단 판막이 설치되면 판막이 확장되어 즉시 작동하기 시작하여 개심술 없이도 정상적인 혈류를 회복합니다. 이 접근법은 기존 수술에 수반되는 신체적 외상과 회복 시간을 크게 줄여 고령의 환자나 수술 위험이 높고 기존 수술이 적합하지 않은 환자들에게 적합한 선택이 될 수 있습니다. 이 분야의 주요 기술은 경카테터 대동맥판막 치환술(TAVR)로, 수술에 비해 낮은 합병증 발생률로 인해 널리 사용되고 있으며, TAVR의 성공은 승모판막과 삼첨판막을 포함한 다른 심장 판막에 대한 경카테터 솔루션의 개발에 박차를 가하고 있습니다. 경카테터 판막 중재시술의 치료 범위를 확대했습니다. 입원 기간 단축, 수술 후 통증 감소, 회복 시간 단축 등 경피적 카테터 심장 판막은 환자의 예후를 개선할 뿐만 아니라 심혈관 치료의 표준 치료법을 변화시키고 있습니다.
경카테터 심장 판막의 혁신은 심장 치료의 미래를 어떻게 형성하고 있는가?
경피적 카테터 심장판막 분야는 재료 과학, 기기 설계 및 시술법의 발전에 힘입어 급속한 기술 혁신을 목격하고 있으며, 그 결과 이러한 구명 장비의 안전성, 유효성 및 다용도성이 향상되고 있습니다. 가장 중요한 혁신 중 하나는 내구성이 향상되고 복잡한 해부학적 구조에 적응할 수 있는 차세대 경피적 카테터 밸브의 개발입니다. 이 새로운 장비에는 니티놀(형상기억합금)과 같은 첨단 소재가 포함되어 있으며, 밸브가 자체적으로 팽창하고 환자의 해부학적 구조에 더 잘 적응할 수 있으며, 더 나은 적합성을 보장하고 누출 및 합병증의 위험을 줄일 수 있습니다. 또 다른 중요한 혁신은 조직 공학 및 생체흡수성 밸브 구성 요소를 사용하여 밸브 장비의 장기적인 성능을 향상시키고 석회화 위험을 최소화하는 것을 목표로 하는 것입니다. 또한 새로운 전달 시스템과 더 작은 카테터 크기는 더 작은 혈관을 통해 접근이 가능하여 혈관 합병증의 위험을 더욱 줄이고, 더 적은 외상으로 시술을 할 수 있게 해주며, 3D 심초음파 및 CT 유도하 내비게이션과 같은 영상 기술도 혁신적입니다. 의 혁신은 시술의 정확성을 높이고, 판막의 정확한 위치를 파악할 수 있게 하여 합병증 위험을 감소시키고 있습니다. 디지털 헬스 기술의 통합도 큰 흐름으로, 일부 기기에는 센서와 무선 모니터링 시스템이 내장되어 있으며, 판막의 성능과 환자의 건강 상태에 대한 실시간 데이터를 제공하여 사전 관리 및 적시에 개입할 수 있도록 돕습니다.
경피적 카테터 심장판막의 채택과 개발에 영향을 미치는 과제는?
경카테터 심장 판막의 보급과 개발은 혁신적인 잠재력에도 불구하고 몇 가지 심각한 문제에 직면해 있습니다. 주요 과제 중 하나는 이러한 시술과 관련된 높은 비용입니다. 경피적 카테터 판막 치환술, 특히 TAVR은 고가의 장비, 전문 교육, 고급 영상 진단 및 시술용 장비를 필요로 하는 자원 집약적인 과정이기 때문에 특히 저소득층이나 농촌 환경에서는 접근성이 제한될 수 있습니다. 또 다른 과제는 환자 선택과 시술 계획의 복잡성입니다. 직접 눈으로 보면서 시행하는 기존의 수술적 판막 치환술과 달리, 경카테터 시술은 판막의 배치를 안내하기 위해 심초음파, CT 스캔, 투시 등의 영상 진단에 크게 의존합니다. 이 때문에 첨단 전문 지식과 정확한 해부학적 평가가 필요하며, 새로운 시술자에게는 학습 곡선이 가파르고 경험이 부족한 센터에서는 이러한 시술의 통합이 복잡해집니다. 또한 경카테터 심장 판막의 장기적인 내구성은 특히 젊은 환자의 경우, 장비의 수명보다 더 길어질 수 있는 장기적인 내구성에 대한 우려가 여전히 존재합니다. 새로운 재료와 디자인은 내구성을 연장하는 것을 목표로 하고 있지만, 10-15년 이상의 장기 결과에 대한 데이터는 여전히 제한적이어서 이러한 시술에 가장 적합한 환자 프로파일을 결정하기가 어렵습니다. 카테터 삽입시 판막누출, 판막 혈전증, 혈관 손상과 같은 합병증 위험도 환자 예후에 영향을 미칠 수 있는 문제입니다. 규제 상황과 상환 문제도 상황을 복잡하게 만들고 있으며, 경피적 카테터 장비의 승인 기준과 상환 기준은 지역마다 크게 다른 경우가 많습니다.
경카테터 심장판막 시장의 성장을 가속하는 요인은 무엇인가?
경카테터 심장판막 시장의 성장은 심혈관 질환의 유병률 증가, 세계 인구의 고령화, 장비 설계 및 시술의 기술 발전 등 여러 가지 요인에 기인합니다. 주요 요인 중 하나는 대동맥판막 협착증 및 기타 심장 판막 질환의 유병률 증가, 특히 노인의 경우 수술 위험이 높기 때문에 저침습적 경피적 카테터 시술이 효과적일 가능성이 높다는 점입니다. 세계 인구의 고령화에 따라 회복이 빠르고 합병증이 적은 최소 침습적 치료에 대한 수요가 증가하고 있으며, 경피적 심장 판막은 점점 더 선호되는 선택이 되고 있습니다. 또 다른 중요한 원동력은 이러한 장비의 임상 적응증 확대입니다. 초기에는 고위험군 수술 후보자를 대상으로 승인된 경피적 카테터 판막 치환술은 임상시험을 통해 수술적 판막 치환술과 동등하거나 그 이상의 치료 효과를 입증하여 현재 저위험군 환자들에게도 적용되고 있습니다. 이러한 적응증 확대로 치료 대상 환자군이 크게 확대되어 시장 성장의 원동력이 되고 있습니다. 재위치 및 회수 가능한 판막, 더 작은 크기의 전달 시스템, 첨단 영상 진단 툴와 같은 기술 혁신으로 인해 시술이 더욱 안전하고 효과적일 수 있게 되었습니다. 또한 심장 전문의, 외과의사, 영상의학과 전문의가 협력하여 최선의 치료 계획을 결정하는 심장 팀 접근법의 채택이 확대되면서 환자 선택과 시술 결과가 개선되고, 경피적 카테터 삽입술의 전반적인 성공률이 향상되고 있습니다. 전문 교육 및 교육 구상에 힘입어 전 세계 병원에서 경피적 카테터 판막 전용 프로그램이 생겨나면서 필요한 인프라와 전문 지식을 구축하는 것도 시장 성장에 기여하고 있습니다. 마지막으로 경피적 카테터 심장 판막의 장점에 대한 인식이 높아지면서 일부 지역의 유리한 상환 정책과 함께 이러한 시술이 더욱 친숙해져 더 높은 채택률을 이끌어내고 있습니다. 이러한 요인들을 종합해 볼 때, 경피적 심장판막 시장은 견고한 성장 궤도를 그리며 중재적 심장학에서 중요한 구성 요소로 자리매김하고 있습니다.
부문
제품 유형(경카테터 대동맥판(TAV), 경카테터 승모판(TMV)), 최종사용자(병원, 카테터 검사실)
조사 대상 기업의 예
Boston Scientific Corporation
Bracco Group
Braile Biomedica
Direct Flow Medical
Edwards Lifesciences
Edwards Lifesciences
JenaValve
Medtronic
St. Jude Medical
Symetis
AI 통합
당사는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.
Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.
관세 영향 계수
Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.
목차
제1장 조사 방법
제2장 개요
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트
기타 중동
아프리카
제4장 경쟁
KSA
영문 목차
영문목차
Global Transcatheter Heart Valves Market to Reach US$43.6 Billion by 2030
The global market for Transcatheter Heart Valves estimated at US$17.3 Billion in the year 2024, is expected to reach US$43.6 Billion by 2030, growing at a CAGR of 16.6% over the analysis period 2024-2030. Transcatheter Aortic Valve (TAV), one of the segments analyzed in the report, is expected to record a 16.9% CAGR and reach US$31.4 Billion by the end of the analysis period. Growth in the Transcatheter Mitral Valve (TMV) segment is estimated at 15.9% CAGR over the analysis period.
The U.S. Market is Estimated at US$4.4 Billion While China is Forecast to Grow at 21.2% CAGR
The Transcatheter Heart Valves market in the U.S. is estimated at US$4.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$11.1 Billion by the year 2030 trailing a CAGR of 21.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.6% and 14.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.8% CAGR.
Global Transcatheter Heart Valves Market - Key Trends and Drivers Summarized
What Makes Transcatheter Heart Valves a Game-Changing Advancement in Cardiology?
Transcatheter heart valves represent a groundbreaking advancement in the field of cardiology, offering a minimally invasive alternative to traditional open-heart surgery for patients suffering from severe heart valve diseases such as aortic stenosis. Unlike conventional surgical valve replacement procedures that require a large chest incision and a heart-lung machine, transcatheter heart valve procedures involve the insertion of a collapsible valve via a catheter, typically through a small incision in the groin or chest. Once in place, the valve expands and starts functioning immediately, restoring normal blood flow without the need for open-heart surgery. This approach significantly reduces the physical trauma and recovery time associated with traditional surgery, making it a viable option for elderly patients or those with high surgical risk who may not be candidates for conventional procedures. The primary technology in this field is Transcatheter Aortic Valve Replacement (TAVR), which has gained widespread adoption due to its proven efficacy and lower complication rates compared to surgical options. The success of TAVR has spurred the development of transcatheter solutions for other heart valves, including the mitral and tricuspid valves, expanding the therapeutic scope of transcatheter valve interventions. With shorter hospital stays, reduced postoperative pain, and faster recovery times, transcatheter heart valves are not only improving patient outcomes but are also transforming the standard of care in cardiovascular treatment.
How Are Innovations in Transcatheter Heart Valves Shaping the Future of Cardiac Care?
The field of transcatheter heart valves is witnessing rapid innovation, driven by advancements in material science, device design, and procedural techniques, which are enhancing the safety, efficacy, and versatility of these life-saving devices. One of the most significant innovations is the development of next-generation transcatheter valves that offer enhanced durability and adaptability to complex anatomies. These new devices incorporate advanced materials such as nitinol-a shape-memory alloy that allows the valves to be self-expanding and more conformable to the patient’s anatomy, ensuring a better fit and reducing the risk of leaks or complications. Another key innovation is the use of tissue-engineered and bioresorbable valve components, which aim to improve the long-term performance of the devices and minimize the risk of calcification. Furthermore, new delivery systems and smaller catheter sizes are making it possible to perform these procedures with even less trauma, allowing access through smaller vessels and further reducing the risk of vascular complications. Innovations in imaging technology, such as 3D echocardiography and CT-guided navigation, are also enhancing procedural precision, enabling more accurate placement of the valve and reducing the risk of complications. The integration of digital health technologies is another major trend, with some devices incorporating sensors and wireless monitoring systems that provide real-time data on valve performance and patient health, allowing for proactive management and timely interventions.
What Challenges Are Affecting the Adoption and Development of Transcatheter Heart Valves?
Despite their transformative potential, the adoption and development of transcatheter heart valves face several significant challenges that need to be addressed to optimize their use and expand their reach. One of the primary challenges is the high cost associated with these procedures. Transcatheter valve replacement, particularly TAVR, is a resource-intensive process that involves expensive devices, specialized training, and sophisticated imaging and procedural equipment, which can limit accessibility, especially in low-income and rural settings. Another challenge is the complexity of patient selection and procedural planning. Unlike traditional surgical valve replacement, which is performed under direct visualization, transcatheter procedures rely heavily on imaging modalities such as echocardiography, CT scans, and fluoroscopy to guide valve placement. This demands a high level of expertise and precise anatomical assessment, making the learning curve steep for new operators and complicating the integration of these procedures into less experienced centers. Additionally, the long-term durability of transcatheter heart valves remains a concern, especially for younger patients who may outlive the lifespan of the device. Although newer materials and designs are aimed at extending durability, data on long-term outcomes beyond 10-15 years is still limited, making it difficult to determine the optimal patient profile for these procedures. The risk of complications, such as paravalvular leak, valve thrombosis, or vascular damage during catheter insertion, also poses challenges that can impact patient outcomes. Regulatory hurdles and reimbursement issues also complicate the landscape, as the approval and reimbursement criteria for transcatheter devices are often vary significantly between regions.
What Factors Are Driving Growth in the Transcatheter Heart Valve Market?
The growth in the transcatheter heart valve market is driven by several factors, including the rising prevalence of cardiovascular diseases, an aging global population, and technological advancements in device design and procedural techniques. One of the primary drivers is the increasing incidence of aortic stenosis and other valvular heart diseases, particularly among the elderly, who are often at higher surgical risk and thus more likely to benefit from minimally invasive transcatheter options. As the global population ages, the demand for less invasive treatments that offer faster recovery and fewer complications is rising, making transcatheter heart valves an increasingly preferred choice. Another key driver is the expansion of clinical indications for these devices. Originally approved for high-risk surgical candidates, transcatheter valve replacement procedures are now being performed in lower-risk patients, following clinical trials that demonstrated comparable or superior outcomes to surgical valve replacement. This broadening of indications is significantly expanding the patient pool eligible for these treatments, driving market growth. Technological advancements are also propelling the market, with innovations such as repositionable and retrievable valves, smaller delivery systems, and advanced imaging tools that are making the procedures safer and more effective. Furthermore, the growing adoption of heart team approaches-where cardiologists, surgeons, and imaging specialists collaborate to determine the best treatment plan-has improved patient selection and procedural outcomes, enhancing the overall success rate of transcatheter interventions. The rise of dedicated transcatheter valve programs in hospitals around the world, supported by specialized training and educational initiatives, is also contributing to market growth by building the necessary infrastructure and expertise. Lastly, increasing awareness of the benefits of transcatheter heart valves, coupled with favorable reimbursement policies in several regions, is making these procedures more accessible and driving higher adoption rates. These factors collectively indicate a robust growth trajectory for the transcatheter heart valve market, positioning it as a key component of interventional cardiology.
SCOPE OF STUDY:
The report analyzes the Transcatheter Heart Valves market in terms of units by the following Segments, and Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 16 Featured) -
Boston Scientific Corporation
Bracco Group
Braile Biomedica
Direct Flow Medical
Edwards Lifesciences
Edwards Lifesciences
JenaValve
Medtronic
St. Jude Medical
Symetis
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Global Economic Update
Transcatheter Heart Valves - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Prevalence of Cardiovascular Diseases and Aging Population Drive Demand for Transcatheter Heart Valve Procedures
Advancements in Valve Design and Delivery Systems Strengthen Business Case for Next-Generation Transcatheter Heart Valves
Growing Preference for Minimally Invasive Cardiac Interventions Expands Addressable Market for Transcatheter Heart Valves in High-Risk Patients
Shift towards Transcatheter Valve-in-Valve (ViV) Procedures Spurs Adoption for Complex and Repeat Interventions
Increasing Use of Transcatheter Aortic Valve Replacement (TAVR) Expands Market Potential in Treating Aortic Stenosis
Rising Adoption of Transcatheter Mitral Valve Replacement (TMVR) Propels Growth in Mitral Regurgitation Treatment
Growing Integration of Imaging and Navigation Technologies Enhances Precision and Success Rates of Transcatheter Valve Procedures
Rising Interest in Personalized and Patient-Specific Heart Valve Solutions Expands Market for Customizable Transcatheter Devices
Focus on Early Detection and Treatment of Heart Valve Disorders Propels Demand for Less Invasive Valve Replacement Solutions
Expanding Application of Transcatheter Heart Valves in Treating Congenital Heart Defects Sustains Market Growth in Pediatric and Adult Congenital Segments
Rising Focus on Expanding Indications Beyond Aortic and Mitral Valves Enhances Market Potential in Treating Tricuspid and Pulmonary Valve Diseases
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 2: World Historic Review for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 3: World 15-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Transcatheter Aortic Valve (TAV) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 5: World Historic Review for Transcatheter Aortic Valve (TAV) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 6: World 15-Year Perspective for Transcatheter Aortic Valve (TAV) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Transcatheter Mitral Valve (TMV) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 8: World Historic Review for Transcatheter Mitral Valve (TMV) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 9: World 15-Year Perspective for Transcatheter Mitral Valve (TMV) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 10: World Transcatheter Heart Valves Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
TABLE 11: World Recent Past, Current & Future Analysis for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 13: World 15-Year Perspective for Hospital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Cath lab by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Cath lab by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 16: World 15-Year Perspective for Cath lab by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 17: USA Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 18: USA Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 19: USA 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 20: USA Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 21: USA Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 22: USA 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
CANADA
TABLE 23: Canada Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 24: Canada Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 25: Canada 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 26: Canada Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 27: Canada Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 28: Canada 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
JAPAN
Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 29: Japan Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 30: Japan Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 31: Japan 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 32: Japan Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 33: Japan Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 34: Japan 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
CHINA
Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 35: China Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 36: China Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 37: China 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 38: China Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 39: China Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 40: China 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
EUROPE
Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 41: Europe Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 42: Europe Historic Review for Transcatheter Heart Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 43: Europe 15-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 44: Europe Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 45: Europe Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 46: Europe 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 47: Europe Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 48: Europe Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 49: Europe 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
FRANCE
Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 50: France Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 51: France Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 52: France 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 53: France Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 54: France Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 55: France 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
GERMANY
Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 56: Germany Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 57: Germany Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 58: Germany 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 59: Germany Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 60: Germany Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 61: Germany 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
ITALY
TABLE 62: Italy Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 63: Italy Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 64: Italy 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 65: Italy Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 66: Italy Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 67: Italy 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
UNITED KINGDOM
Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 68: UK Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 69: UK Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 70: UK 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 71: UK Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 72: UK Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 73: UK 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
SPAIN
TABLE 74: Spain Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 75: Spain Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 76: Spain 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 77: Spain Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 78: Spain Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 79: Spain 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
RUSSIA
TABLE 80: Russia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 81: Russia Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 82: Russia 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 83: Russia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 84: Russia Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 85: Russia 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: Rest of Europe Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 88: Rest of Europe 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 90: Rest of Europe Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 91: Rest of Europe 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 93: Asia-Pacific Historic Review for Transcatheter Heart Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 94: Asia-Pacific 15-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 96: Asia-Pacific Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 97: Asia-Pacific 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 99: Asia-Pacific Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 100: Asia-Pacific 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
AUSTRALIA
Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
TABLE 101: Australia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 102: Australia Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 103: Australia 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 104: Australia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 105: Australia Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 106: Australia 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
INDIA
Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
TABLE 107: India Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 108: India Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 109: India 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 110: India Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 111: India Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 112: India 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
SOUTH KOREA
TABLE 113: South Korea Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 114: South Korea Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 115: South Korea 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 116: South Korea Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 117: South Korea Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 118: South Korea 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 120: Rest of Asia-Pacific Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 121: Rest of Asia-Pacific 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 123: Rest of Asia-Pacific Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
LATIN AMERICA
Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
TABLE 125: Latin America Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 126: Latin America Historic Review for Transcatheter Heart Valves by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 127: Latin America 15-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
TABLE 128: Latin America Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 129: Latin America Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 130: Latin America 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 131: Latin America Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 132: Latin America Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 133: Latin America 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
ARGENTINA
TABLE 134: Argentina Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 135: Argentina Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 136: Argentina 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 137: Argentina Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 138: Argentina Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 139: Argentina 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
BRAZIL
TABLE 140: Brazil Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 141: Brazil Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 142: Brazil 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 143: Brazil Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 144: Brazil Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 145: Brazil 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
MEXICO
TABLE 146: Mexico Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 147: Mexico Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 148: Mexico 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 149: Mexico Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 150: Mexico Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 151: Mexico 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 153: Rest of Latin America Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 154: Rest of Latin America 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 156: Rest of Latin America Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 157: Rest of Latin America 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
MIDDLE EAST
Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
TABLE 158: Middle East Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 159: Middle East Historic Review for Transcatheter Heart Valves by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 160: Middle East 15-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
TABLE 161: Middle East Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 162: Middle East Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 163: Middle East 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 164: Middle East Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 165: Middle East Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 166: Middle East 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
IRAN
TABLE 167: Iran Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 168: Iran Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 169: Iran 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 170: Iran Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 171: Iran Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 172: Iran 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
ISRAEL
TABLE 173: Israel Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 174: Israel Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 175: Israel 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 176: Israel Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 177: Israel Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 178: Israel 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
SAUDI ARABIA
TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 180: Saudi Arabia Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 181: Saudi Arabia 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 183: Saudi Arabia Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 184: Saudi Arabia 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
TABLE 185: UAE Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 186: UAE Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 187: UAE 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 188: UAE Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 189: UAE Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 190: UAE 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 192: Rest of Middle East Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 193: Rest of Middle East 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 195: Rest of Middle East Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 196: Rest of Middle East 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
AFRICA
Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
TABLE 197: Africa Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 198: Africa Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 199: Africa 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
TABLE 200: Africa Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 201: Africa Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 202: Africa 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030